General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial

This study examined general medical illnesses and their association with clinical features of bipolar disorder.

[1]  J. Lindenmayer,et al.  Relationship between metabolic syndrome and cognition in patients with schizophrenia , 2012, Schizophrenia Research.

[2]  M. Berk,et al.  Is the safety of lithium no longer in the balance? , 2012, The Lancet.

[3]  J. Calabrese,et al.  Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles , 2012, European Neuropsychopharmacology.

[4]  J. Calabrese,et al.  Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment – Moderate dose Use Study (LiTMUS) for bipolar disorder , 2012, Clinical trials.

[5]  C. Blanco,et al.  The burden of obesity among adults with bipolar disorder in the United States , 2011, Bipolar disorders.

[6]  J. García-Campayo,et al.  Medical comorbidity in recurrent versus first‐episode depressive patients , 2011, Acta psychiatrica Scandinavica.

[7]  G. Kirov,et al.  Effects of chronic lithium treatment on renal function. , 2010, Journal of affective disorders.

[8]  M. Alda,et al.  Cross-prevalence of migraine and bipolar disorder. , 2010, Bipolar disorders.

[9]  J. Calabrese,et al.  Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. , 2010, Bipolar disorders.

[10]  A. Beekman,et al.  Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. , 2010, The Journal of clinical psychiatry.

[11]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[12]  T. Mark,et al.  Health and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder , 2009, Journal of clinical psychopharmacology.

[13]  J. Calabrese,et al.  Lithium treatment — moderate dose use study (LiTMUS) for bipolar disorder: rationale and design , 2009, Clinical trials.

[14]  Amanda T. Woodward,et al.  Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2009, The Journal of clinical psychiatry.

[15]  F. Zitman,et al.  Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use , 2009, Acta psychiatrica Scandinavica.

[16]  David J Kupfer,et al.  Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. , 2009, Bipolar disorders.

[17]  A. Kilbourne,et al.  Co-occurring Conditions and Health-Related Quality of Life in Patients With Bipolar Disorder , 2009, Psychosomatic medicine.

[18]  J. Ayuso-Mateos,et al.  Functioning and Disability in Bipolar Disorder: An Extensive Review , 2009, Psychotherapy and Psychosomatics.

[19]  J. Calabrese,et al.  Medical and substance use comorbidity in bipolar disorder. , 2009, Journal of affective disorders.

[20]  A. Fagiolini,et al.  The effects of undertreated chronic medical illnesses in patients with severe mental disorders. , 2009, The Journal of clinical psychiatry.

[21]  J. Calabrese,et al.  Differential interactions between comorbid anxiety disorders and substance use disorder in rapid cycling bipolar I or II disorder. , 2008, Journal of affective disorders.

[22]  D. Kupfer,et al.  Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. , 2008, Journal of psychiatric research.

[23]  Del D. Miller,et al.  Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. , 2008, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[24]  P. Hauser,et al.  Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. , 2008, Bipolar disorders.

[25]  D. Kupfer,et al.  Medical burden in late-life bipolar and major depressive disorders. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[26]  M. De Hert,et al.  Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. , 2008, Bipolar disorders.

[27]  M. Maj,et al.  Physical illness and schizophrenia: a review of the literature , 2007, Acta psychiatrica Scandinavica.

[28]  A. Kilbourne,et al.  Nutrition and exercise behavior among patients with bipolar disorder. , 2007, Bipolar disorders.

[29]  R. Kessler,et al.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.

[30]  M. Fava,et al.  Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. , 2007, Primary care companion to the Journal of clinical psychiatry.

[31]  S. Kennedy,et al.  Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. , 2006, Psychiatric services.

[32]  D. Kupfer,et al.  Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. , 2006, The Journal of clinical psychiatry.

[33]  J. Lieberman,et al.  Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III , 2005, Schizophrenia Research.

[34]  B. Grant,et al.  Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2004, Archives of general psychiatry.

[35]  M H Trivedi,et al.  The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation , 2004, Psychological Medicine.

[36]  M. Fava,et al.  Axis III disorders in treatment-resistant major depressive disorder , 2003, Psychiatry Research.

[37]  T. Suppes,et al.  Correlates of overweight and obesity in 644 patients with bipolar disorder. , 2002, The Journal of clinical psychiatry.

[38]  A. Rush,et al.  High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure , 2002, Biological Psychiatry.

[39]  L. Judd,et al.  A brief assessment of psychosocial functioning of subjects with bipolar I disorder: the LIFE-RIFT. Longitudinal Interval Follow-up Evaluation-Range Impaired Functioning Tool. , 2000, The Journal of nervous and mental disease.

[40]  Robert M. Post,et al.  Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP , 1997, Psychiatry Research.

[41]  Y. Conwell,et al.  Validation of a Measure of Physical Illness Burden at Autopsy: The Cumulative Illness Rating Scale , 1993, Journal of the American Geriatrics Society.

[42]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[43]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[44]  B. Linn,et al.  CUMULATIVE ILLNESS RATING SCALE , 1968, Journal of the American Geriatrics Society.

[45]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[46]  D. Allison,et al.  Is percentage body fat differentially related to body mass index in Hispanic Americans, African Americans, and European Americans? , 2003, The American journal of clinical nutrition.

[47]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[48]  J. Endicott,et al.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. , 1993, Psychopharmacology bulletin.